inhA promoter mutations: A gateway to extensively drug-resistant tuberculosis in South Africa?
dc.contributor.author | Muller B. | |
dc.contributor.author | Streicher E.M. | |
dc.contributor.author | Hoek K.G.P. | |
dc.contributor.author | Tait M. | |
dc.contributor.author | Trollip A. | |
dc.contributor.author | Bosman M.E. | |
dc.contributor.author | Coetzee G.J. | |
dc.contributor.author | Chabula-Nxiweni E.M. | |
dc.contributor.author | Hoosain E. | |
dc.contributor.author | Gey Van Pittius N.C. | |
dc.contributor.author | Victor T.C. | |
dc.contributor.author | Van Helden P.D. | |
dc.contributor.author | Warren R.M. | |
dc.date.accessioned | 2011-05-15T15:53:44Z | |
dc.date.available | 2011-05-15T15:53:44Z | |
dc.date.issued | 2011 | |
dc.description.abstract | SETTING: Western Cape and Eastern Cape Provinces, South Africa. OBJECTIVE: To assess the potential association between the evolution of extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis and mutations in the inhA promoter or the katG gene. DESIGN: Analysis of the frequency distribution of isoniazid (INH) resistance conferring mutations in a population sample of drug-resistant isolates of M. tuberculosis. RESULTS: In the Western Cape and Eastern Cape Provinces, the percentage of isolates exhibiting inhA promoter mutations increased significantly from respectively 48.4% and 62.4% in multidrug-resistant tuberculosis (MDR-TB) isolates to 85.5% and 91.9% in XDR isolates. Data from the Western Cape revealed that significantly more XDR-TB isolates showed mutations in the inhA promoter than in katG (85.5% vs. 60.9%, P < 0.01), while the respective proportions were equal for INH-resistant non-MDR-TB isolates (∼30%). CONCLUSIONS: inhA promoter mutations are strongly associated with XDR-TB in South Africa. We suggest that this is due to the dual resistance to ethionamide and (low-dose) INH conferred by inhA promoter mutations. The use of molecular probe assays such as the Geno-Type® MTBDRplus assay, which allows the detection of inhA promoter mutations, could enable treatment regimens to be adjusted depending on the pharmacogenetic properties of the mutations detected. © 2011 The Union. | |
dc.description.version | Article | |
dc.identifier.citation | International Journal of Tuberculosis and Lung Disease | |
dc.identifier.citation | 15 | |
dc.identifier.citation | 3 | |
dc.identifier.issn | 10273719 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/8785 | |
dc.title | inhA promoter mutations: A gateway to extensively drug-resistant tuberculosis in South Africa? | |
dc.type | Article |